Expression and Potential Biomarkers of Regulators for M7G RNA Modification in Gliomas
Gliomas are the most frequent primary malignant brain tumors of the central nervous system, causing significant impairment and death. There is mounting evidence that N7 methylguanosine (m7G) RNA dysmethylation plays a significant role in the development and progression of cancer. However, the expres...
Main Authors: | Zhen Chen, Zhe Zhang, Wei Ding, Jie-hui Zhang, Zi-long Tan, Yu-ran Mei, Wei He, Xiao-jing Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-05-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fneur.2022.886246/full |
Similar Items
-
METTL1 promotes neuroblastoma development through m7G tRNA modification and selective oncogenic gene translation
by: Ying Huang, et al.
Published: (2022-09-01) -
N7-methylguanosin regulators-mediated methylation modification patterns and characterization of the immune microenvironment in lower-grade glioma
by: Aierpati Maimaiti, et al.
Published: (2023-03-01) -
A novel prognostic 7-methylguanosine signature reflects immune microenvironment and alternative splicing in glioma based on multi-omics analysis
by: Zihan Wang, et al.
Published: (2022-08-01) -
Identification of a Novel N7-Methylguanosine-Related LncRNA Signature Predicts the Prognosis of Hepatocellular Carcinoma and Experiment Verification
by: Chou Yang, et al.
Published: (2022-12-01) -
Aggrephagy-related gene signature correlates with survival and tumor-associated macrophages in glioma: Insights from single-cell and bulk RNA sequencing
by: Xiaowei Zhang, et al.
Published: (2024-01-01)